Neurimmune is a clinical-stage biopharmaceutical company building next generation antibody therapeutics. The company pioneers amyloid depletion as a novel therapeutic mechanism to treat CNS and related protein aggregation diseases including Alzheimer’s disease, amyotrophic lateral sclerosis and ATTR cardiomyopathy.

Emerging Therapies

View all

Early versions (v1.0 to v1.01) struggled with AMD hardware.

: The game credits were updated to include additional third-party software.

Scientific Publications